Related Experiment Video
Updated: Apr 10, 2026
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune Encephalomyelitis
Klara Soukup1, Angela Halfmann1, Marie Le Bras1
1Department of Immunology, St. Anna Children's Cancer Research Institute, 1090 Vienna, Austria;
Abstract:
Dendritic cell (DC)-mediated inflammation induced via TLRs is promoted by MAPK-activated protein kinase (MK)-2, a substrate of p38 MAPK. In this study we show an opposing role of MK2, by which it consolidates immune regulatory functions in DCs through modulation of p38, ERK1/2-MAPK, and STAT3 signaling. During primary TLR/p38 signaling, MK2 mediates the inhibition of p38 activation and positively cross-regulates ERK1/2 activity, leading to a reduction of IL-12 and IL-1α/β secretion. Consequently, MK2 impairs secondary autocrine IL-1α signaling in DCs, which further decreases the IL-1α/p38 but increases the anti-inflammatory IL-10/STAT3 signaling route. Therefore, the blockade of MK2 activity enables human and murine DCs to strengthen proinflammatory effector mechanisms by promoting IL-1α-mediated Th1 effector functions in vitro. Furthermore, MK2-deficient DCs trigger Th1 differentiation and Ag-specific cytotoxicity in vivo. Finally, wild-type mice immunized with LPS in the presence of an MK2 inhibitor strongly accumulate Th1 cells in their lymph nodes. These observations correlate with a severe clinical course in DC-specific MK2 knockout mice compared with wild-type littermates upon induction of experimental autoimmune encephalitis. Our data suggest that MK2 exerts a profound anti-inflammatory effect that prevents DCs from prolonging excessive Th1 effector T cell functions and autoimmunity.
Insights
MAPK-activated protein kinase 2 (MK2) has an anti-inflammatory role in dendritic cells (DCs). Blocking MK2 enhances pro-inflammatory responses, potentially worsening autoimmune diseases.
Area of Science:
- Immunology
- Cellular signaling
- Inflammation research
Background:
- Dendritic cell (DC) activation via Toll-like receptors (TLRs) involves p38 MAPK.
- MAPK-activated protein kinase 2 (MK2) is a downstream target of p38 MAPK.
- MK2's role in DC-mediated inflammation is complex and requires further elucidation.
Purpose of the Study:
- To investigate the opposing role of MK2 in regulating DC immune functions.
- To determine how MK2 modulates p38, ERK1/2-MAPK, and STAT3 signaling pathways.
- To assess the impact of MK2 blockade on DC-mediated inflammation and autoimmunity.
Main Methods:
- Analysis of p38, ERK1/2-MAPK, and STAT3 signaling in DCs.
- Assessment of cytokine secretion (IL-12, IL-1α/β, IL-10).
- In vitro and in vivo studies using MK2 inhibitors and MK2-deficient mice.
- Evaluation of Th1 differentiation, cytotoxicity, and experimental autoimmune encephalitis (EAE) course.
Main Results:
- MK2 inhibits p38 activation and enhances ERK1/2 activity during TLR signaling.
- MK2 reduces IL-12 and IL-1α/β secretion while promoting IL-10/STAT3 signaling.
- MK2 blockade in DCs promotes IL-1α-mediated Th1 effector functions in vitro.
- MK2 deficiency in DCs leads to enhanced Th1 differentiation and cytotoxicity in vivo.
- MK2 inhibition in wild-type mice increases Th1 cell accumulation in lymph nodes.
- DC-specific MK2 knockout mice exhibit a severe clinical course in EAE.
Conclusions:
- MK2 exerts a significant anti-inflammatory effect by limiting excessive Th1 responses.
- MK2 acts as a crucial regulator of immune homeostasis in DCs.
- Targeting MK2 could have implications for managing autoimmune diseases.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
08:03Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
